Flow Neuroscience develops a non-invasive brain stimulation technology called tDCS for the treatment of depression.

Flow Neuroscience

Parasym is a neurotechnology company focused on developing innovative neuromodulation treatment that significantly improves quality of life. Self-described as pioneering a new class of treatment that uses bioelectrical signals targeted to neural circuits of organs.

Parasym

BrainQ develops investigational therapy aimed at reversing disability after a stroke using AI-powered electromagnetic stimulation, self-described as a means to help users achieve freedom from disability from home.

Metric
Company Name	Flow Neuroscience	Parasym	BrainQ
Symbol
MSH ID	COM:FLOWNEUROSCIENCE	CO:PARASYM	COM:BRAINQTECH
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Mental Health Services	Medical Devices	Medical Devices
Country	GB	US	IL
Stage
Employee Count
Website	flowneuroscience.com	parasym.co	brainqtech.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:FLOWNEUROSCIENCE

Flow Neuroscience

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue